Geode Capital Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.6M | Buy |
657,350
+52,702
| +9% | +$2.22M | ﹤0.01% | 2136 |
|
|
2026
Q1 | $33.4M | Buy |
604,648
+35,537
| +6% | +$1.69M | ﹤0.01% | 1717 |
|
|
2025
Q4 | $21.3M | Buy |
569,111
+21,951
| +4% | +$892K | ﹤0.01% | 1966 |
|
|
2025
Q3 | $22.1M | Sell |
547,160
-7,767
| -1% | -$257K | ﹤0.01% | 1949 |
|
|
2025
Q2 | $14.2M | Buy |
554,927
+7,841
| +1% | +$171K | ﹤0.01% | 2138 |
|
|
2025
Q1 | $11.7M | Buy |
547,086
+31,107
| +6% | +$695K | ﹤0.01% | 2197 |
|
|
2024
Q4 | $10.8M | Buy |
515,979
+8,510
| +2% | +$197K | ﹤0.01% | 2326 |
|
|
2024
Q3 | $11.4M | Buy |
507,469
+27,201
| +6% | +$525K | ﹤0.01% | 2297 |
|
|
2024
Q2 | $8.06M | Buy |
480,268
+22,013
| +5% | +$354K | ﹤0.01% | 2462 |
|
|
2024
Q1 | $5.93M | Sell |
458,255
-193
| -0% | -$2.31K | ﹤0.01% | 2608 |
|
|
2023
Q4 | $5.31M | Buy |
458,448
+22,072
| +5% | +$249K | ﹤0.01% | 2677 |
|
|
2023
Q3 | $5.57M | Buy |
436,376
+26,109
| +6% | +$370K | ﹤0.01% | 2583 |
|
|
2023
Q2 | $5.62M | Buy |
410,267
+21,236
| +5% | +$304K | ﹤0.01% | 2615 |
|
|
2023
Q1 | $5.96M | Buy |
389,031
+989
| +0.3% | +$15.1K | ﹤0.01% | 2557 |
|
|
2022
Q4 | $5.2M | Buy |
388,042
+6,370
| +2% | +$85.4K | ﹤0.01% | 2645 |
|
|
2022
Q3 | $5.07M | Buy |
381,672
+12,167
| +3% | +$210K | ﹤0.01% | 2670 |
|
|
2022
Q2 | $7.07M | Buy |
369,505
+7,395
| +2% | +$140K | ﹤0.01% | 2491 |
|
|
2022
Q1 | $7.22M | Buy |
362,110
+9,161
| +3% | +$185K | ﹤0.01% | 2579 |
|
|
2021
Q4 | $7.21M | Sell |
352,949
-2
| -0% | -$43 | ﹤0.01% | 2665 |
|
|
2021
Q3 | $7.6M | Sell |
352,951
-3,399
| -1% | -$81.8K | ﹤0.01% | 2662 |
|
|
2021
Q2 | $10.3M | Buy |
356,350
+8,919
| +3% | +$241K | ﹤0.01% | 2433 |
|
|
2021
Q1 | $8.48M | Buy |
347,431
+48,474
| +16% | +$1.09M | ﹤0.01% | 2469 |
|
|
2020
Q4 | $5.8M | Sell |
298,957
-8,476
| -3% | -$156K | ﹤0.01% | 2523 |
|
|
2020
Q3 | $5.35M | Sell |
307,433
-4,986
| -2% | -$106K | ﹤0.01% | 2353 |
|
|
2020
Q2 | $8.21M | Sell |
312,419
-2,787
| -0.9% | -$69.2K | ﹤0.01% | 2047 |
|
|
2020
Q1 | $7.62M | Buy |
315,206
+2,980
| +1% | +$72.8K | ﹤0.01% | 1905 |
|
|
2019
Q4 | $7.75M | Buy |
312,226
+10,040
| +3% | +$233K | ﹤0.01% | 2183 |
|
|
2019
Q3 | $6.45M | Buy |
302,186
+10,839
| +4% | +$297K | ﹤0.01% | 2229 |
|
|
2019
Q2 | $9.26M | Buy |
291,347
+15,238
| +6% | +$478K | ﹤0.01% | 2012 |
|
|
2019
Q1 | $9.11M | Buy |
276,109
+27,572
| +11% | +$858K | ﹤0.01% | 1956 |
|
|
2018
Q4 | $7.99M | Buy |
248,537
+12,371
| +5% | +$467K | ﹤0.01% | 1927 |
|
|
2018
Q3 | $10.1M | Buy |
236,166
+15,670
| +7% | +$740K | ﹤0.01% | 1907 |
|
|
2018
Q2 | $10.2M | Buy |
220,496
+16,971
| +8% | +$751K | ﹤0.01% | 1856 |
|
|
2018
Q1 | $8.08M | Buy |
203,525
+13,988
| +7% | +$518K | ﹤0.01% | 1914 |
|
|
2017
Q4 | $6.35M | Sell |
189,537
-9,439
| -5% | -$335K | ﹤0.01% | 2072 |
|
|
2017
Q3 | $7.37M | Buy |
198,976
+3,965
| +2% | +$149K | ﹤0.01% | 1959 |
|
|
2017
Q2 | $7.22M | Buy |
195,011
+32,142
| +20% | +$1.05M | ﹤0.01% | 1881 |
|
|
2017
Q1 | $4.58M | Buy |
162,869
+14,655
| +10% | +$413K | ﹤0.01% | 2168 |
|
|
2016
Q4 | $4.34M | Buy |
148,214
+4,748
| +3% | +$130K | ﹤0.01% | 2152 |
|
|
2016
Q3 | $3.9M | Buy |
143,466
+3,269
| +2% | +$73.9K | ﹤0.01% | 2119 |
|
|
2016
Q2 | $2.62M | Buy |
140,197
+3,134
| +2% | +$65.4K | ﹤0.01% | 2307 |
|
|
2016
Q1 | $3.71K | Buy |
137,063
+11,787
| +9% | +$338K | ﹤0.01% | 2064 |
|
|
2015
Q4 | $3.77M | Buy |
125,276
+16,854
| +16% | +$541K | ﹤0.01% | 2070 |
|
|
2015
Q3 | $3.43M | Buy |
108,422
+1,684
| +2% | +$61.5K | ﹤0.01% | 2088 |
|
|
2015
Q2 | $4.16M | Buy |
106,738
+7,774
| +8% | +$268K | ﹤0.01% | 2021 |
|
|
2015
Q1 | $3.5M | Buy |
98,964
+4,483
| +5% | +$144K | ﹤0.01% | 2076 |
|
|
2014
Q4 | $2.98M | Sell |
94,481
-4,636
| -5% | -$128K | ﹤0.01% | 2156 |
|
|
2014
Q3 | $2.22M | Buy |
99,117
+2,989
| +3% | +$59.9K | ﹤0.01% | 2300 |
|
|
2014
Q2 | $2.11M | Buy |
+96,128
| New | +$1.83M | ﹤0.01% | 2342 |
|
Other funds holding PAHC
CM
DIA
Geode Capital Management's PAHC Position: Q2 2026 in Review
Geode Capital Management increased its Phibro Animal Health (PAHC) stake by 8.7% in Q2 2026, buying an estimated $2.22M and bringing the position to 657,350 shares worth $20.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2136.
Geode Capital Management first reported a position in PAHC in Q2 2014 and has held it in 49 quarters since. The position peaked at $33.4M in Q1 2026. 195 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Geode Capital Management held 657,350 shares of Phibro Animal Health worth $20.6M as of Q2 2026.
- Geode Capital Management bought 52,702 Phibro Animal Health shares in Q2 2026, an estimated $2.22M.
- Phibro Animal Health made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2136 holding.
- Geode Capital Management first reported a position in Phibro Animal Health in Q2 2014 and has held it in 49 quarters since.
- Geode Capital Management's Phibro Animal Health position peaked at $33.4M in Q1 2026.
- 195 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.